Delivery Order SPE2DB24D2205-SPE2DB24FDUXK
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,837.51 firm fixed-price delivery order is for the supply of TREMFYA 100 MG/ML INJECTOR, a pharmaceutical product. The contract has an ultimate completion date of March 11, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,403.47 firm-fixed-price delivery order is for TREMFYA 100 MG/ML SYRINGEML, a specialty pharmaceutical product. The contract has an ultimate completion date of March 5, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,944.51 delivery order is for the supply of TREMFYA 100 MG/ML SYRINGEML, a specialty pharmaceutical product. The contract has an ultimate completion date of October 17, 2024 and is a firm fixed-price delivery order. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,187.33 delivery order contract is for the supply of TREMFYA 100 MG/ML INJECTORML, a specialty medication. The contract has an ultimate completion date of October 29, 2024 and is a firm fixed price, delivery order contract type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $13,083.48 Firm Fixed Price Delivery Order is for the pharmaceutical product TREMFYA 100 MG/ML SYRINGEML, with a completion date of November 13, 2023. AmerisourceBergen, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC serves as the primary...
- This federal contract award was issued by the Medical Supply Chain, a component of the Defense Logistics Agency (DLA), to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,315.47 firm fixed-price delivery order is for TREMFYA 100 MG/ML SYRINGEML, a medication. The contract has a period of performance through March 6, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $26,677.98, is for the delivery of TREMFYA 100 MG/ML INJECTORML. It is a firm fixed-price delivery order contract with a completion date of January 23, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award, valued at $15,799.89, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the medical product "TREMFYA 100 MG/ML SYRINGEML" and has a completion date of November 5, 2024. The contract is a firm fixed-price arrangement without any set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $8,528.55 firm fixed-price delivery order is for the supply of Tremfya 100 mg/ml syringes. The contract has an ultimate completion date of August 29, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to...
- This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of TREMFYA 100 MG/ML INJECTORML. The award, valued at $15,743.59, is a firm fixed-price delivery order with an ultimate completion date of October 17, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth $999,999,999 through November 2026, which serves as a primary vehicle for...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB24FDUXKDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,682.37 firm fixed-price delivery order is for the supply of TREMFYA 100 MG/ML SYRINGEML, a medical product, with a completion date of June 3, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award is not designated as a set-aside requirement, indicating open competition. Additionally, Amerisourcebergen maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.7k | 5/31/24 |